ICAP partnered with the MOH and National AIDS Centers in Kazakhstan, Kyrgyzstan, and Tajikistan to build national capacity to provide high-quality HIV prevention, care, and treatment services, providing enhanced technical assistance and mentoring to HIV care and...
ICAP is partnering with MOHs and National AIDS Centers in Kazakhstan, Kyrgyzstan, and Tajikistan to build national capacity to provide high-quality HIV prevention, care, and treatment services, providing enhanced technical assistance and mentoring to HIV care and...
ICAP collaborated with the MOHSW and Zanzibar to build capacity to expand HIV prevention, care, and treatment services at all levels of the health system, including psychosocial support to people living with HIV, VMMC and HIV prevention for key populations (people who...
A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. ICAP...
This study investigated the experimental microbicide gel tenofovir to protect women against HIV. The study provided information on how much vaginal tenofovir gel, when used in combination with common vaginal products, will interfere with the local and or systemic...
